• Users Online: 105
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
CASE REPORT
Year : 2020  |  Volume : 21  |  Issue : 2  |  Page : 153-155

Dexmedetomidine in a patient with unrepaired congenital cyanotic heart disease


1 Department of Cardiac Anesthesia, SGRRIM and HS, Dehradun, Uttarakhand, India
2 Department of Anesthesiology, SGRRIM and HS, Dehradun, Uttarakhand, India
3 Department of Anaesthesia, AIIMS, Rishikesh, Uttarakhand, India

Correspondence Address:
Dr. Nishith Govil
Department of Anesthesiology, SGRRIM and HS, Dehradun - 248 001 Uttarakhand
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/TheIAForum.TheIAForum_27_20

Rights and Permissions

The challenges in a patient with unrepaired congenital cyanotic heart disease (CCHD) requiring controlled hypotension are to prevent a further increase in the right-to-left (R-L) shunt by maintaining systemic vascular resistance, controlling pulmonary vascular resistance (PVR), decreasing oxygen consumption, and preventing arrhythmia and hypovolemia. To the best of our knowledge, combination of ketamine and dexmedetomidine has not been used in a patient with unrepaired CCHD to keep hemodynamic stable, preventing reversal of shunt and arrhythmias while providing controlled hypotension. The rationale of using combination of intravenous ketamine and dexmedetomidine is to counteract sympathoinhibitory effects of dexmedetomidine with the cardiostimulatory effects of ketamine, thus maintaining a stable hemodynamic in cases with R-L shunt. Another benefit in CCHD is that dexmedetomidine decreases the incidence of arrhythmia intraoperatively and decreases dynamic response of the right ventricular outflow tract induced by pain, thus decreasing R-L shunt. Dexmedetomidine encourages protective mechanisms during hypoxia as in patients with CCHD by lowering anti-ischemic responses such as lactate production and a modest decrease in the PVR. Dexmedetomidine provides controlled hypotension and uneventful recovery due to its lowering of stress response of surgery and opioid sparing effect and decreases the incidence of emergence agitation and postoperative nausea and vomiting.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed601    
    Printed6    
    Emailed0    
    PDF Downloaded99    
    Comments [Add]    

Recommend this journal